127 related articles for article (PubMed ID: 562590)
1. Bone changes during prednisone treatment.
Deding A; Tougaard L; Krogh Jensen M; Rodbro P
Acta Med Scand; 1977; 202(4):253-5. PubMed ID: 562590
[TBL] [Abstract][Full Text] [Related]
2. Bone mineralization and bone mineral content in primary hyperparathyroidism.
Tougaard L; Hau C; Rodbro P; Ditzel J
Acta Endocrinol (Copenh); 1977 Feb; 84(2):314-9. PubMed ID: 576347
[TBL] [Abstract][Full Text] [Related]
3. [Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica].
Lovschall S
Ugeskr Laeger; 1977 Oct; 139(44):2618-20. PubMed ID: 145049
[No Abstract] [Full Text] [Related]
4. The degree of bone mineralization in hyperthyroidism estimated from the phosphorus to hydroxyproline ratio in bone.
Tougaard L
Acta Endocrinol (Copenh); 1976 Mar; 81(3):482-6. PubMed ID: 946341
[TBL] [Abstract][Full Text] [Related]
5. The degree of bone mineralization in chronic renal failure estimated from phosphorus/hydroxyproline ratio in bone biopsies.
Schaadt O; Tougaard L
Acta Med Scand; 1975; 198(1-2):91-3. PubMed ID: 1166829
[TBL] [Abstract][Full Text] [Related]
6. Polymyalgia rheumatica and giant cell arteritis.
Healey LA; Wilske KR
West J Med; 1984 Jul; 141(1):64-7. PubMed ID: 6475043
[TBL] [Abstract][Full Text] [Related]
7. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
[TBL] [Abstract][Full Text] [Related]
8. The degree of mineralization in normal bone tissue estimated as the phosphorus to hydroxyproline ratio.
Tougaard L
Scand J Clin Lab Invest; 1975 May; 35(3):285-8. PubMed ID: 1153925
[TBL] [Abstract][Full Text] [Related]
9. Polymyalgia rheumatica.
Huddleston RE
Br J Hosp Med; 1986 Sep; 36(3):225. PubMed ID: 3768612
[No Abstract] [Full Text] [Related]
10. Corticosteroids for rheumatic disease. 2. Effects on disease states, effects on bone.
Jamieson T
Postgrad Med; 1986 Apr; 79(5):247-8, 250. PubMed ID: 3485794
[No Abstract] [Full Text] [Related]
11. Bone mineral in lumbar spine, femoral neck and femoral shaft measured by dual photon absorptiometry with 153-gadolineum in prednisone treatment.
Schaadt O; Bohr H
Adv Exp Med Biol; 1984; 171():201-8. PubMed ID: 6720459
[No Abstract] [Full Text] [Related]
12. Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
Gutteridge DH; Mastaglia FL
Intern Med J; 2017 Oct; 47(10):1199-1201. PubMed ID: 28994265
[TBL] [Abstract][Full Text] [Related]
13. Polymyalgia rheumatica and giant cell arteritis.
Unwin B; Williams CM; Gilliland W
Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
[TBL] [Abstract][Full Text] [Related]
15. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Pioro MH
Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
[TBL] [Abstract][Full Text] [Related]
16. Familial aggregation of polymyalgia rheumatica and giant cell arteritis.
Liang GC; Simkin PA; Hunder GG; Wilske KR; Healey LA
Arthritis Rheum; 1974; 17(1):19-24. PubMed ID: 4810661
[No Abstract] [Full Text] [Related]
17. [Phosphorus/hydroxyprolin-ratio in bone tissue. A method of estimating the degree of mineralization in bone tissue].
Tougaard L
Ugeskr Laeger; 1975 Aug; 137(34):1945-7. PubMed ID: 1166533
[No Abstract] [Full Text] [Related]
18. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
Ferraccioli G; Salaffi F; De Vita S; Casatta L; Bartoli E
J Rheumatol; 1996 Apr; 23(4):624-8. PubMed ID: 8730115
[TBL] [Abstract][Full Text] [Related]
19. [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
Doury P; Fabresse FX; Pattin S; Eulry F; Celton H; Larroque P
Ann Med Interne (Paris); 1984; 135(1):31-5. PubMed ID: 6703568
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
Wadman B; Werner I
Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
